Tamsulosin
Prescription ·Exploratory record · not publication-reviewed ·Updated July 13, 2026
Tamsulosin is a selective alpha-1A adrenergic receptor antagonist used to treat lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH). Its selectivity for the alpha-1A subtype, which predominates in the prostate and bladder neck, allows for effective symptom relief with less orthostatic hypotension than non-selective alpha blockers.
Exploratory record, not a reviewed medical publication.
See the editorial and medical-review policies for the publication gate.
This generated database record has not completed a claim-level review by a qualified human medical reviewer. Bibliography links and evidence labels are not approval. The page remains available for reference and is excluded from search indexing.
What the research says.
A quick, data-only summary. The full evidence, dosing, and sources are below.
Tamsulosin is a selective alpha-1A adrenergic receptor antagonist used to treat lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH). NutriStack rates the supporting evidence as strong. Common adult dosing is 0.4 mg once daily, 30 minutes after the same meal each day; may increase to 0.8 mg if inadequate response after 2-4 weeks (as prescribed by your physician), though a prescriber sets the actual dose. This profile indexes 10 sources.
The bottom line
Evidence rating strong. Most-documented uses: rapid improvement in urinary flow rate and luts symptoms, less orthostatic hypotension than non-selective alpha blockers, no requirement for dose titration. 10 sources indexed (2018–2025), with 0 interaction records on file.
How it works, mechanistically.
Core mechanism
Selectively blocks alpha-1A adrenergic receptors in the smooth muscle of the prostate, prostatic capsule, prostatic urethra, and bladder neck. This relaxes smooth muscle tone, reducing urethral resistance and improving urine flow without significantly affecting vascular alpha-1B receptors (minimizing blood pressure effects).8
Dosing & protocol.
Take approximately 30 minutes after the same meal each day for consistent absorption. Fasting significantly increases bioavailability and may increase side effects.
Full safety detail.
Side effects
- Abnormal ejaculation (retrograde ejaculation)
- Dizziness
- Rhinitis (nasal congestion)
- Headache
- Intraoperative floppy iris syndrome (IFIS) during cataract surgery
- Orthostatic hypotension (less common than with non-selective alpha blockers)
Sources, by evidence tier.
Numbered references. Citations throughout the page link here.
Meta-analyses & systematic reviews
5- 1Comparing Tamsulosin vs. Silodosin prior to Ureteroscopy: A Network Meta-Analysis of Randomized Controlled TrialsPMIDRamadhan M, Benzouak T, Ali Y et al. · World journal of urology · 2025
Ramadhan M, Benzouak T, Ali Y et al.. Comparing Tamsulosin vs. Silodosin prior to Ureteroscopy: A Network Meta-Analysis of Randomized Controlled Trials. World journal of urology. 2025
- 2The effect of tamsulosin in postoperative urinary retention: a meta-analysis of randomized controlled trialsPMIDGao B, Zhang D, Wang Y et al. · Naunyn-Schmiedeberg's archives of pharmacology · 2023
Gao B, Zhang D, Wang Y et al.. The effect of tamsulosin in postoperative urinary retention: a meta-analysis of randomized controlled trials. Naunyn-Schmiedeberg's archives of pharmacology. 2023
- 3The Effect of Preoperative Tamsulosin on Ureteral Navigation, Operation, and Safety: A Systematic Review and Meta-AnalysisPMIDCheng C, Ma Y, Wen J et al. · Urologia internationalis · 2023
Cheng C, Ma Y, Wen J et al.. The Effect of Preoperative Tamsulosin on Ureteral Navigation, Operation, and Safety: A Systematic Review and Meta-Analysis. Urologia internationalis. 2023
- 4A Systematic Review and Meta-Analysis of the Efficacy and Safety of Tamsulosin Plus Tadalafil Compared With Tamsulosin Alone in Treating Males With Lower Urinary Tract Symptoms Secondary to Benign Prostrate HyperplasiaPMIDZhou R, Che X, Zhou Z et al. · American journal of men's health · 2023
Zhou R, Che X, Zhou Z et al.. A Systematic Review and Meta-Analysis of the Efficacy and Safety of Tamsulosin Plus Tadalafil Compared With Tamsulosin Alone in Treating Males With Lower Urinary Tract Symptoms Secondary to Benign Prostrate Hyperplasia. American journal of men's health. 2023
- 5Safety of Tamsulosin: A Systematic Review of Randomized Trials with a Focus on Women and ChildrenPMIDKaplan SA, Chughtai BI · Drug safety · 2018
Kaplan SA, Chughtai BI. Safety of Tamsulosin: A Systematic Review of Randomized Trials with a Focus on Women and Children. Drug safety. 2018
Reference material
5- 6Narayan P, Lepor H. Long-term, open-label, phase III multicenter study of tamsulosin in benign prostatic hyperplasia. Urology. 2001;57(3):466-470.Source linkedPMID
- 7Nickel JC et al. Comparison of dutasteride and finasteride for treating benign prostatic hyperplasia: the Enlarged Prostate International Comparator Study (EPICS). BJU Int. 2011;108(3):388-394.Source linkedPMID
- 8Roehrborn CG, Schwinn DA. Alpha1-adrenergic receptors and their inhibitors in lower urinary tract symptoms and benign prostatic hyperplasia. J Urol. 2004;171(3):1029-1035.Source linkedPMID
- 9Ye Z, Zeng G, Yang H et al.. Efficacy and Safety of Tamsulosin in Medical Expulsive Therapy for Distal Ureteral Stones with Renal Colic: A Multicenter, Randomized, Double-blind, Placebo-controlled Trial. European urology. 2018Source linkedPMID
- 10Zhang Z, Lv L, Jiang F et al.. Real-world safety assessment of tamsulosin based on adverse event analysis from the FAERS database. Scientific reports. 2025Source linkedPMID
Common questions.
Quick answers about Tamsulosin, drawn from the data on this page.
What is Tamsulosin?
Tamsulosin is a selective alpha-1A adrenergic receptor antagonist used to treat lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH). Its selectivity for the alpha-1A subtype, which predominates in the prostate and bladder neck, allows for effective symptom relief with less orthostatic hypotension than non-selective alpha blockers.
What is Tamsulosin used for?
Commonly cited benefits of Tamsulosin include: Rapid improvement in urinary flow rate and LUTS symptoms; Less orthostatic hypotension than non-selective alpha blockers; No requirement for dose titration; Can be used off-label to facilitate ureteral stone passage. NutriStack rates the overall evidence as strong.
What is a typical dose of Tamsulosin?
A typical adult dose of Tamsulosin is 0.4 mg once daily, 30 minutes after the same meal each day; may increase to 0.8 mg if inadequate response after 2-4 weeks (as prescribed by your physician). The commonly recommended form is Modified-release capsule (0.4 mg). These are general ranges, not personalized advice; confirm the right dose with a clinician.
What are the side effects of Tamsulosin?
Reported side effects include abnormal ejaculation (retrograde ejaculation), dizziness, rhinitis (nasal congestion), headache, intraoperative floppy iris syndrome (ifis) during cataract surgery, orthostatic hypotension (less common than with non-selective alpha blockers). This is educational information; check with a healthcare professional before use.
How strong is the evidence for Tamsulosin?
NutriStack rates this as Strong, meaning multiple high-quality meta-analyses or systematic reviews converge on the same finding. Full tier criteria are at https://nutristackapp.com/methodology/evidence-tiers.
Use this with your stack
Tamsulosin in NutriStack.
Add it to your stack, see how it interacts with everything else you take, and get a Stack Score that updates the moment it does.